Digital Health Acquisition (DHAC) Competitors $1.17 -0.02 (-1.68%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock DHAC vs. ENZ, BRTX, BGLC, MGRX, SSY, ATIP, ACON, VSEE, OTRK, and NIVFShould you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Enzo Biochem (ENZ), Biorestorative Therapies (BRTX), BioNexus Gene Lab (BGLC), Mangoceuticals (MGRX), SunLink Health Systems (SSY), ATI Physical Therapy (ATIP), Aclarion (ACON), VSee Health (VSEE), Ontrak (OTRK), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry. Digital Health Acquisition vs. Its Competitors Enzo Biochem Biorestorative Therapies BioNexus Gene Lab Mangoceuticals SunLink Health Systems ATI Physical Therapy Aclarion VSee Health Ontrak NewGenIvf Group Digital Health Acquisition (NASDAQ:DHAC) and Enzo Biochem (NYSE:ENZ) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Does the media refer more to DHAC or ENZ? In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled Enzo Biochem'saverage media sentiment score. Company Overall Sentiment Digital Health Acquisition Neutral Enzo Biochem Neutral Which has preferable earnings & valuation, DHAC or ENZ? Digital Health Acquisition has higher earnings, but lower revenue than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDigital Health AcquisitionN/AN/AN/AN/AN/AEnzo Biochem$29.09M0.59-$26.08MN/AN/A Do institutionals and insiders believe in DHAC or ENZ? 1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by insiders. Comparatively, 11.4% of Enzo Biochem shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, DHAC or ENZ? Digital Health Acquisition has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Is DHAC or ENZ more profitable? Digital Health Acquisition has a net margin of 0.00% compared to Enzo Biochem's net margin of -75.34%. Digital Health Acquisition's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets Digital Health AcquisitionN/A N/A N/A Enzo Biochem -75.34%-7.96%-5.49% SummaryEnzo Biochem beats Digital Health Acquisition on 4 of the 7 factors compared between the two stocks. Get Digital Health Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHAC vs. The Competition Export to ExcelMetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ ExchangeMarket Cap$4.22M$181.57M$489.32M$9.04BDividend YieldN/A5.41%N/A4.00%P/E RatioN/A2.48N/A20.24Price / SalesN/A435.632.80118.07Price / CashN/A74.78N/A58.10Price / BookN/A6.474.535.67Net IncomeN/A$3.67M-$28.22M$249.21M7 Day Performance6.36%0.54%12.16%3.28%1 Month Performance-7.14%3.23%23.11%3.95%1 Year Performance-86.79%72.44%108.53%20.98% Digital Health Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHACDigital Health AcquisitionN/A$1.17-1.7%N/A-88.9%$4.22MN/A0.002,021Gap UpENZEnzo BiochemN/A$0.33-14.8%N/A-69.3%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBiorestorative Therapies2.7619 of 5 stars$1.58-0.4%$18.00+1,036.4%-15.3%$11.88M$400K-1.087BGLCBioNexus Gene Lab0.4149 of 5 stars$6.31-7.5%N/A+36.0%$11.36M$9.51M0.0030Gap DownMGRXMangoceuticals0.8391 of 5 stars$1.55+1.6%N/A-97.8%$7.99M$620K-0.333News CoverageGap UpSSYSunLink Health SystemsN/A$0.89-2.1%N/A+10.7%$6.24M$31.09M6.331,376Positive NewsATIPATI Physical Therapy0.191 of 5 stars$0.99-1.0%N/A-80.2%$4.37M$741.86M-0.055,600Upcoming EarningsGap UpACONAclarion2.2826 of 5 stars$7.50-2.3%$11,758.50+156,680.0%-99.7%$4.35M$50K0.007News CoverageVSEEVSee Health1.2025 of 5 stars$1.17-1.7%$5.00+327.4%N/A$4.21MN/A0.00N/AOTRKOntrak2.8977 of 5 stars$0.49+1.0%$45.00+9,121.3%-84.1%$2.06M$10.85M-0.03250News CoverageNegative NewsHigh Trading VolumeNIVFNewGenIvf GroupN/A$0.93-5.8%N/A-99.5%$494K$5.43M0.00N/APositive News Related Companies and Tools Related Companies Enzo Biochem Alternatives Biorestorative Therapies Alternatives BioNexus Gene Lab Alternatives Mangoceuticals Alternatives SunLink Health Systems Alternatives ATI Physical Therapy Alternatives Aclarion Alternatives VSee Health Alternatives Ontrak Alternatives NewGenIvf Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DHAC) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digital Health Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digital Health Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DHAC Stock Alerts